Transformative all-stock transaction expected to present an estimated $200 millionin run-rate cost synergies
Combined company expected to have significant financial and operating leverage with $6.5 billion in Net Revenue and $1.5 billion in Adjusted EBITDA1, including estimated synergies, for the twelve-month period ended March 31, 2024
Read more at newswire.ca